Sherwin-Williams has clawed back 4.1% this week to $311.25, yet the more notable development is what options traders are signalling: this is the most aggressively call-heavy positioning the stock has seen all year, and it has deepened further even as fundamentals remain under pressure.
The options picture is striking. The put/call ratio has collapsed to 0.55 — three standard deviations below its 20-day mean of 0.70, and barely above the 52-week low of 0.51. That reading does not emerge from a market hedging downside risk; it reflects concentrated demand for calls in a stock that is still down 7.8% on the month. This is a meaningful shift from a week ago, when the PCR registered 0.61 and the z-score was only -0.83. The call bias has since deepened materially, even as the stock was recovering from May lows. Whether this reflects genuine conviction in a bounce or tactical positioning ahead of the July 21 earnings date is the question the data raises but does not answer.
Short positioning is a secondary story here, and a modest one. SI has risen 16% over the past month to 2.5% of the free float — a real move, but from a low base. Absolute levels remain well within the range of ordinary noise for a stock this size. Borrow costs tripled in a week to 0.49%, a headline-grabbing percentage change from a near-zero starting point. The absolute rate, however, is barely meaningful. Availability is extraordinarily loose at 6,545% — roughly 65 shares available for every one currently borrowed. There is no squeeze dynamic at work. The CTB move reflects a small pickup in borrowing demand, not any tightening of supply.
The Street is constructive but cautious. Eleven analysts rate the stock a buy against ten holds, with the consensus mean target at $381 — implying roughly 22% upside from current levels. Post-Q1 earnings, however, the direction of travel has been negative. JPMorgan trimmed its target from $385 to $365, and Evercore — the lone firm that subsequently lifted estimates — only pushed back to $400 after having cut a week before. Most analysts maintained ratings while nudging targets lower, a posture that says "we believe in the franchise but the near-term is softer than we expected." Wells Fargo went a step further, downgrading to Equal-Weight in April before trimming the target again after earnings. The PE has pulled back to about 25x and EV/EBITDA near 18x — compressed from 30-day highs, but still not cheap for a company guiding to flat-to-low single digit sales growth in 2025. The 12-month forward EPS YoY increase factor scores in the 91st percentile, which explains why the buy case has not collapsed; the growth expectation is intact even if near-term demand is soft.
Peer context is worth noting. RPM and PPG — the closest coatings comparables by correlation — each gained over 5.5% on the week, slightly outpacing SHW's 4.1% bounce. Axalta Coating Systems led the group at nearly 9%. The sector is broadly recovering from April weakness, and SHW is participating, but it has not yet recaptured relative leadership within the group.
The next data point that matters is the July 21 earnings release. After Q1 produced a 5.4% single-day drop followed by a further 1.6% loss over the following five sessions, the bar for the market reaction is now lower. Whether the call positioning currently building represents early positioning into that print — or simply reflects a view that the worst of the macro headwinds are priced — is what makes the setup worth watching heading into summer.
See the live data behind this article on ORTEX.
Open SHW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
